Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PLAY -12%, KMTS -8.7%
Other news:
- CNTB -34.3% (reports Phase 2 asthma data for rademikibart; plans FDA talks after COPD readout)
- ENVA -17.5% (withdraws bank regulatory applications; reaffirms guidance and intends to accelerate repurchases)
- TRMD -7.4% (prices 9.0M-share secondary offering at $32.25/share)
- AXON -3.1% (launches $1.0 bln 0% convertible senior notes offering due 2031)
- CTNM -2.8% (Phase 2 Results for JNJ-5120/PIPE-307 for the Treatment of Major Depressive Disorder; did not meet primary endpoint)
- SYY -2.4% (prices 12.35 mln-share common stock offering at $81.00/share)
- NIQ -1.8% (expands Homescan shopper panels in Singapore and Hong Kong; launches Digital Purchase GeoAudiences in five European markets)
- BNTC -1.7% (files for $200 mln mixed securities shelf offering)
- INGM -1.5% (outlines long-term strategy, intelligence-led transformation and multi-year financial framework at Capital Markets Day)